[PDF][PDF] CD8+ T cell–mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-α/β signaling

S Hida, K Ogasawara, K Sato, M Abe, H Takayanagi… - Immunity, 2000 - cell.com
S Hida, K Ogasawara, K Sato, M Abe, H Takayanagi, T Yokochi, T Sato, S Hirose, T Shirai…
Immunity, 2000cell.com
The balanced action of cytokines is known to be critical for the maintenance of homeostatic
immune responses. Here, we report the development of an inflammatory skin disease
involving CD8+ T cells, in mice lacking the transcription factor, interferon regulatory factor-2
(IRF-2). CD8+ T cells exhibit in vitro hyper-responsiveness to antigen stimulation,
accompanied with a notable upregulation of the expression of genes induced by interferon-
α/β (IFN-α/β). Furthermore, both disease development and CD8+ T cell abnormality are …
Abstract
The balanced action of cytokines is known to be critical for the maintenance of homeostatic immune responses. Here, we report the development of an inflammatory skin disease involving CD8+ T cells, in mice lacking the transcription factor, interferon regulatory factor-2 (IRF-2). CD8+ T cells exhibit in vitro hyper-responsiveness to antigen stimulation, accompanied with a notable upregulation of the expression of genes induced by interferon-α/β (IFN-α/β). Furthermore, both disease development and CD8+ T cell abnormality are suppressed by the introduction of nullizygosity to the genes that positively regulate the IFN-α/β signaling pathway. IRF-2 may represent a unique negative regulator, attenuating IFN-α/β-induced gene transcription, which is necessary for balancing the beneficial and harmful effects of IFN-α/β signaling in the immune system.
cell.com